CARDIONOVUM GmbH
Monika Mroczkiewicz currently serves as the Quality and Regulatory Affairs Director at CARDIONOVUM GmbH since October 2021, having previously held the position of Quality and Regulatory Affairs Manager. Prior to this role, Monika directed the Medical Devices Certification Department at Polskie Centrum Badań i Certyfikacji S.A. from July 2013 to September 2021 and also served as Deputy Director and Specialist within the same department. Monika holds a Doctor of Philosophy (PhD) in Chemical Technology with a focus on bioanalytics from Warsaw University of Technology, as well as a Postgraduate Degree in Quality Management from SGH Warsaw School of Economics, and a Master of Science in Engineering in Biotechnology from Warsaw University of Technology.
This person is not in any offices
CARDIONOVUM GmbH
CARDIONOVUM, a medical technology company based in Bonn, Germany, develops and commercializes innovative medical devices such as the new generation of DCB and drug-eluting stents for the treatment of coronary and peripheral artery disease. The company’s pioneering range of DCBs is based on the SAFEPAX® paclitaxel coating matrix which has the lowest wash-off rates on the market. The company’s strong commitment to clinical research ensures a continually deepening and expanding evidence-base in support of the clinical benefits of our products. Pioneers in medical devices. The worldwide first CE-approved DCB. With the first DCB market introduction, CARDIONOVUM contributed significantly to the establishment of a new medical device therapy to treat coronary and peripheral artery disease effectively. CARDIONOVUM consists of R & D staff, with the longest and most profound experience, in developing clinically advanced DCB and DES cardiovascular devices. “Live Deserves the Best”